Heat Therapy and Peripheral Artery Disease

ConditionsPeripheral Arterial Disease Cardiovascular Health Vascular Function Intermittent Claudication Peripheral Vascular Diseases

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorManchester Metropolitan University

About this trial

The purpose of the study is to assess the efficacy of a novel 8 week heat therapy intervention in intermittent claudication compared to usual care controls. Participants will be enrolled on a wait-list control randomised trial testing physiological, mechanistic, and health related outcome measures.

Eligibility criteria

Qualifiers

• Aged > 18 years

ABPI < 0.9 at rest or a drop of 20mmHG after exercise testing

Diagnosed with IC

Able to walk unaided

Disqualifiers

• Walking impairment for a reason other than PAD

Critical limb ischaemia/rest pain

Asymptomatic PAD

Active cancer treatment

Trial design

Treatments tested in this trial

Heat Therapy Intervention

Treatment groups

70 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Manchester Metropolitan University

Lead sponsor

British Heart Foundation

Collaborator

Source ClinicalTrials.gov